No Reason to Get Excited about Athenahealth (ATHN), Thinks Oppenheimer

February 8, 2013 2:10 PM EST Send to a Friend
Get Alerts ATHN Hot Sheet
Price: $122.50 +1.79%

Rating Summary:
    15 Buy, 13 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 29 | Down: 45 | New: 4
Trade ATHN Now!
Join SI Premium – FREE
On Thursday Athenahealth (NASDAQ: ATHN) reported reported Q4 results, with EPS topping estimates by a penny on revenue of $116.3 million, just shy of consensus estimates of $116.97 million.

Commenting on the news, analyst Bret Jones of Oppenheimer said, "We believe the higher growth rate in collections versus revenue is indicative of pricing pressure. Discounting on enterprise deals needs to be monitored, we think, given the increased dependence on enterprise wins. However, with essentially in-line doc adds and a strong pipeline for 2013, we only expect the shares to be modestly off."

Unsurprisingly, Oppenheimer has a Perform rating on athenahealth.

For an analyst ratings summary and ratings history on athenahealth (NASDAQ: ATHN) click here. For more ratings news on athenahealth click here.

Shares of athenahealth closed at $88.37 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Add Your Comment